SCHEMBL172668

SCHEMBL172668

CC(C)CN(C)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.54
ALDH1A1 P00352 3/20 0.54
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
PRMT8 Q9NR22 1/20 0.53
LMNA P02545 2/20 0.52
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
ADRA2B P18089 1/20 0.52
ADRA2C P18825 1/20 0.52
HTR2A P28223 1/20 0.52
ADRA1A P35348 1/20 0.52
OPRK1 P41145 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KCNH2 Q12809 1/20 0.52
USP2 O75604 1/20 0.52
CYP3A4 P08684 1/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
PYCR1 P32322 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16209876 0.83 CARM1 (0.55) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL16264696 0.83 TSHR (0.56) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL14578374 0.83 CARM1 (0.60) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL4530889 0.83 DNM1 (0.54) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL4530213 0.83 DNM1 (0.54) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL25234019 0.83 ALDH1A1 (0.50) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL3211466 0.83 CARM1 (0.55) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL13995586 0.83 TSHR (0.50) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL1006191 0.83 CARM1 (0.55) TSHRALDH1A1CARM1PRMT6PRMT8
SCHEMBL18436476 0.82 ADRA2B (0.67) TSHRALDH1A1CARM1PRMT6PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10081805-B1 Signaling compositions, methods, and systems for effecting plant growth and crop enhancement KamTec, LLC (US) 2018-09-25 US claimed
US-20140283198-A1 Signaling Compositions, Methods, and Systems for Effecting Plant Growth and Crop Enhancement KamTec, LLC (US) 2014-09-18 US claimed
US-20140283199-A1 Signaling Compositions, Methods, and Systems for Effecting Plant Burndown and Herbicide Enhancement KamTec (US) 2014-09-18 US claimed
JP-2005538978-A 2005-12-22 JP claimed
EP-1523474-A1 CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS Solvay Solexis S.p.A. (IT) 2005-04-20 EP claimed
WO-2004007452-A1 CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS SOLVAY SOLEXIS S.P.A. (IT) 2004-01-22 WO claimed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
US-20230050819-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. 2023-02-16 US disclosed
US-10940139-B2 Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease SHY Therapeutics LLC (US) 2021-03-09 US disclosed
US-10889556-B2 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-01-12 US disclosed
US-20200121660-A1 COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, INC. 2020-04-23 US disclosed
US-20190106398-A1 COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-04-11 US disclosed
US-10081805-B1 Signaling compositions, methods, and systems for effecting plant growth and crop enhancement KamTec, LLC (US) 2018-09-25 US disclosed
EP-1955697-A1 2-AMINOBENZAMIDE DERIVATIVE Astellas Pharma Inc. (JP) 2008-08-13 EP disclosed
US-20070208049-A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto NEUROCRINE BIOSCIENCES, INC. (US) 2007-09-06 US disclosed
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-7196106-B2 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK & CO., INC (US) 2007-03-27 US disclosed
US-6951958-B1 Solid phase parallel synthesis of tertiary amines ACADIA PHARMACEUTICALS INC. (US) 2005-10-04 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190106398-A1 COMPOSITIONS AND METHODS FOR INHIBITING INFLUENZA RNA POLYMERASE PA ENDONUCLEASE POLRMT, RNASE1, POLM TSHR 3661/4885ALDH1A1 2389/4885CARM1 2332/4885
US-20040097552-A1 Cyanothiophene derivatives, compositions containing such compounds and methods of use GLP1R, GPR119, GCGR TSHR 106/4885ALDH1A1 2652/4885CARM1 4213/4885
US-20200121660-A1 COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE HRAS, KRAS, NRAS TSHR 4307/4885ALDH1A1 3448/4885CARM1 2593/4885
US-20230050819-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE CYFIP2, TPX2, ATXN2 TSHR 1535/4885ALDH1A1 4788/4885CARM1 1812/4885
US-10940139-B2 Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease HRAS, KRAS, NRAS TSHR 4307/4885ALDH1A1 3448/4885CARM1 2593/4885
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL TSHR 3784/4885ALDH1A1 172/4885CARM1 1158/4885
US-20070208049-A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto GNRHR, GHRHR, LHCGR TSHR 53/4885ALDH1A1 3443/4885CARM1 3355/4885
US-10889556-B2 Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease POLRMT, RNASE1, POLM TSHR 3661/4885ALDH1A1 2389/4885CARM1 2332/4885
US-20140283199-A1 Signaling Compositions, Methods, and Systems for Effecting Plant Burndown and Herbicide Enhancement BOLA2; BOLA2B, DBNL, EBPL TSHR 2361/4885ALDH1A1 3134/4885CARM1 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.